VX09-809-102 COHORT 4: A Phase 2, Multicenter, Double-Blind, Placebo-Controlled, Multiple-Dose Study to Evaluate the Safety, Tolerability, Efficacy, Pharmacokinetics, and Pharmacodynamics of Lumacaftor Monotherapy, and Lumacaft

Project: Research project

Project Details

StatusFinished
Effective start/end date10/14/1310/14/15

Funding

  • Vertex Pharmaceuticals Incorporated